Doctors should keep their patients informed about being paid to enrol them in a clinical trial. Post-marketing surveillance or phase 4 clinical trials - are a signicnificant part of medical research. It involves giving patients a new drug// and the family doctor reporting any problems that might arise. The post-marketing phase will involve many more patients than those who can take part in previous trials and can be an important way of revealing uncommon side effects.

Doctors will often be paid for their trouble in enrolling patients and keeping records. Researchers in the US felt that it's not always clear to the patient that the doctor is getting a cash benefit from their participation and this is wrong. It goes against the idea of informed consent - because the patient doesn't have all the facts - and it could lead to conflict of interests.


'"/>




Page: 1
Related medicine news :

1. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
2. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
3. Clinical Comparisons Between ADHD Drugs Are Less
4. A Novel System For Clinical Banking Of Umbilical Cord Blood
5. Clinical Renal Trails Do Not Have Sufficient Women Participants
6. Clinical Trials of New Drug Febuxostat Show Promise in Gout Treatment
7. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
8. Green Tea Consumption Found To Improve Clinical Outcome In Cancer Patients
9. Cancer Clinical Research in India
10. New Generation Clinical Trials Could Save Time And Money, Improve Patient Care
11. Clinical Impact of Activity and Abdominal Pressure on Pelvic Floor Dysfunction Need to Be Further Analyzed